Beneficial Alzheimer's therapies, update on prevention efforts focused at ADI International Conference

Beneficial Alzheimer's therapies that don't use drugs, and an update on prevention efforts, are the focus of the second day's plenary sessions at the 25th International Conference of Alzheimer's Disease International (ADI), March 12, 2010 at the Grand Hotel Palace, Thessaloniki, Greece.

Prof. Robert Woods of Bangor University, Gwynedd, United Kingdom, says, "Psychological therapies have been used with people with dementia for at least 50 years, aiming to improve or maintain cognition, functional abilities, and quality of life, and reduce distress, anxiety, depression and behavioral difficulties."

In his presentation at the conference, titled "Psychological Interventions with People with Dementia," Woods will share encouraging findings from recent research, including cognitive stimulation and behavioral approaches. Effect sizes comparable to drug therapies have been reported, with fewer side effects, according to Woods.

Prof. Esme Moniz-Cook of the Institute of Rehabilitation, Hull York Medical School, United Kingdom, will define psychosocial intervention in dementia care and review some of the interventions that are known to help. She will discuss recent research conducted in the UK. Mary Mittleman, D.P.H. of the New York University, Langone Medical Center, USA will talk about her experience "Translating the NYU Caregiver Intervention from Research to Practice Settings."

The day's second plenary session will address the topic of "Can We Prevent Alzheimer's." Scheduled topics/presenters are:

- The Prevention Working Group of ADI. Barry Reisberg, M.D., New York University School of Medicine, USA. - Can Physical and Mental Exercise Prevent Cognitive Decline? Michael Valenzuela, Ph.D., University of New South Wales, Sydney, Australia. - Helicobacter Pylori & Neurodegenerative Diseases. Kountouras Jannis, M.D., Ph.D., Aristotle University, Thessaloniki, Greece. - Brain Donation by People with Dementia and Carers. Prof. Paul Francis, King's College London, England.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New neuroimaging marker may identify persons at risk of dementia in future clinical trials